Interference of canakinumab with commercial IL-1β ELISAs
Research output: Contribution to journal › Letter › Contributed › peer-review
Contributors
Details
| Original language | English |
|---|---|
| Pages (from-to) | 6-7 |
| Number of pages | 2 |
| Journal | Clinical Immunology |
| Volume | 205 |
| Publication status | Published - Aug 2019 |
| Peer-reviewed | Yes |
External IDs
| Scopus | 85065723482 |
|---|
Keywords
Keywords
- Canakinumab, Caspase-1, ELISA, IL-1β, Inflammasome, Whole blood assay